DOAC vs placebo
Total VTE · ambulatory cancer patients receiving chemotherapy
DOAC probably leads to lower any VTE compared with placebo (moderate certainty).
1 finding from 1 review
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy 2020 · Cochrane Headline outcomes onlyRR 0.55 [0.34, 0.9]2 studies · 1404 participantsModerate